Tabula Rasa HealthCare, Inc. Quarterly Cost of Revenue in USD from Q2 2016 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Tabula Rasa HealthCare, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2016 to Q2 2023.
  • Tabula Rasa HealthCare, Inc. Cost of Revenue for the quarter ending June 30, 2023 was $67.5M, a 19.2% increase year-over-year.
  • Tabula Rasa HealthCare, Inc. Cost of Revenue for the twelve months ending June 30, 2023 was $258M, a 22.3% increase year-over-year.
  • Tabula Rasa HealthCare, Inc. annual Cost of Revenue for 2022 was $233M, a 20.3% increase from 2021.
  • Tabula Rasa HealthCare, Inc. annual Cost of Revenue for 2021 was $193M, a 20.4% increase from 2020.
  • Tabula Rasa HealthCare, Inc. annual Cost of Revenue for 2020 was $161M, a 11.4% decline from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $258M $67.5M +$10.9M +19.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $247M $67.5M +$14.8M +28.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $233M $63M +$12.5M +24.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-10
Q3 2022 $220M $60.2M +$9.02M +17.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $211M $56.6M +$9.01M +18.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $202M $52.7M +$8.74M +19.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $193M $50.6M +$39M +336% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $154M $51.2M +$1.97M +3.99% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $152M $47.6M -$4.08M -7.89% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $157M $44M -$4.09M -8.52% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $161M $11.6M -$36.5M -75.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-10
Q3 2020 $197M $49.2M +$2.81M +6.04% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $194M $51.7M +$6.54M +14.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $188M $48.1M +$6.41M +15.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $181M $48.1M +$9.55M +24.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $172M $46.4M +$11.4M +32.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $160M $45.2M +$12.7M +39.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $148M $41.7M +$10M +31.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $138M $38.5M +$8.97M +30.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $129M $35.1M +$11.6M +49.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $117M $32.4M +$11.4M +54.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $106M $31.7M +$12M +61.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $93.7M $29.6M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $23.5M +$6.28M +36.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $21M +$4.85M +30.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $19.7M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q3 2016 $17.2M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $16.1M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.